Wikidata

(Q36693091)

English

Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2).

scientific article published on 7 November 2006

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2). (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17190618
retrieved
15 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q36693091&oldid=1561109561"